Ingredient
Trisodium NTA
Trisodium NTA is flagged for pregnancy, trying to conceive, breastfeeding, postpartum, PCOS and general use. The concern behind the strongest flag is carcinogen concern and fetal development.
- Trisodium Nitrilotriacetate
- Nitrilotriacetic Acid Trisodium Salt
- NTA
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Trisodium NTA and pregnancy
Not Recommended
- Carcinogen concern
- Fetal development
Trisodium NTA is a chelating agent that binds to metal ions in cosmetic formulations. While it serves a functional purpose in products, its classification as a possible carcinogen and potential for systemic absorption raise concerns during pregnancy. Animal studies have shown that NTA can cross the placental barrier and has been associated with developmental effects at high doses. The IARC's classification as a Group 2B carcinogen (possibly carcinogenic to humans) is based on evidence of kidney and urinary tract tumors in rodents. While cosmetic exposure is topical and likely results in lower systemic levels than in animal studies, the potential for any exposure during critical periods of fetal development makes this ingredient concerning. No specific prohibition exists from ACOG, but the general medical recommendation is to minimize exposure to potential carcinogens during pregnancy. Many dermatologists advise pregnant women to choose products with safer chelating alternatives like EDTA, phytic acid, or gluconates. Given the availability of these alternatives, avoiding NTA during pregnancy is a reasonable precautionary measure.
Trisodium NTA and breastfeeding
Caution Advised
- Carcinogen concern
- Passes into breast milk
Trisodium NTA is used as a chelating agent in cosmetics and personal care products. While topical application results in limited systemic absorption, the ingredient's classification as a possible carcinogen raises theoretical concerns for breastfeeding mothers. There is limited specific data on NTA transfer to breast milk. However, as a water-soluble small molecule, there is potential for some systemic absorption through skin, particularly with repeated use or application to large surface areas. The compound's ability to chelate essential minerals like calcium and magnesium could theoretically affect nutrient levels if significant absorption occurred. While no direct evidence suggests harm to breastfed infants from topical maternal use, many lactation consultants and dermatologists recommend choosing products with alternative chelating agents during breastfeeding as a precautionary approach. If using products containing NTA, avoid application to breast areas and ensure products are fully absorbed or removed before breastfeeding.
Trisodium NTA and postpartum
Caution Advised
- Carcinogen concern
For postpartum women not breastfeeding, the concerns with Trisodium NTA are similar to those for the general population: primarily its classification as a possible carcinogen. The postpartum period doesn't present unique vulnerabilities to this ingredient beyond general health considerations. Women may prefer to choose products with safer chelating alternatives, particularly if using products frequently or on large body areas. The ingredient is being phased out by many manufacturers, so alternative products are increasingly available.
Trisodium NTA and trying to conceive
Not Recommended
- Carcinogen concern
- Fertility effects
Women trying to conceive are generally advised to minimize exposure to potential carcinogens and endocrine-disrupting chemicals. While topical cosmetic use of Trisodium NTA results in much lower exposure than in animal toxicology studies, the preconception period is a critical time to optimize health and reduce unnecessary chemical exposures. Some animal studies suggest high doses of NTA may affect mineral metabolism and potentially reproductive function, though human data is lacking. The prudent approach during the preconception period is to choose products with alternative chelating agents that don't carry these theoretical concerns.
Trisodium NTA and PCOS
Caution Advised
- Endocrine disruptor
Trisodium NTA functions as a chelating agent in cosmetics with no direct benefits for PCOS-related skin concerns. Some research suggests NTA may have weak estrogenic activity, which could theoretically be relevant for women with PCOS who often have hormonal imbalances. While the evidence for endocrine disruption from topical cosmetic use is limited, women with PCOS are often advised to minimize exposure to potential hormone-disrupting chemicals. The compound's ability to chelate minerals might also theoretically interfere with mineral balance, though this is more of a concern with ingestion than topical use. Given that PCOS is a hormone-sensitive condition and that safer chelating alternatives exist, women with PCOS may prefer to avoid products containing NTA. Alternative chelating agents like EDTA or phytic acid provide the same benefits without potential hormonal concerns.
Trisodium NTA and general use
Caution Advised
- Carcinogen concern
Trisodium NTA serves as an effective chelating agent in cosmetics, helping to stabilize formulations and improve product performance. However, its classification by IARC as a Group 2B carcinogen (possibly carcinogenic to humans) has led many manufacturers to reformulate products using alternative chelating agents. The carcinogenicity classification is based on animal studies showing kidney and urinary tract tumors at high oral doses. The relevance to topical cosmetic use in humans is debated, as systemic absorption from skin application is significantly lower than oral exposure. However, the SCCS has expressed concerns, and some jurisdictions have implemented restrictions. Many cosmetic companies are voluntarily removing NTA from formulations in favor of safer alternatives like EDTA, phytic acid, or gluconate salts. For consumers concerned about potential risks, choosing products with these alternative chelating agents is straightforward, as they provide equivalent functionality without the carcinogenicity concerns.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store